HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao Liang Selected Research

Metalloproteins

12/2019Fenton-reaction-stimulative nanoparticles decorated with a reactive-oxygen-species (ROS)-responsive molecular switch for ROS amplification and triple negative breast cancer therapy.
10/2010[Effect of adenovirus delivered tissue inhibitor of metalloproteinases 3 on the irradiation sensitivity of human papillomavirus positive cervical cancer cells].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao Liang Research Topics

Disease

143Neoplasms (Cancer)
11/2022 - 12/2002
36Hepatocellular Carcinoma (Hepatoma)
10/2022 - 06/2009
23Neoplasm Metastasis (Metastasis)
01/2022 - 12/2002
18Infections
07/2022 - 04/2004
18Inflammation (Inflammations)
01/2022 - 08/2013
17Atherosclerosis
06/2022 - 02/2010
11Hemorrhage
09/2022 - 04/2004
11Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 09/2014
11Breast Neoplasms (Breast Cancer)
01/2020 - 09/2009
9COVID-19
03/2022 - 01/2020
8Liver Neoplasms (Liver Cancer)
06/2022 - 09/2006
8Pain (Aches)
01/2022 - 12/2010
8Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 01/2007
8Carcinoma (Carcinomatosis)
12/2021 - 05/2009
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 05/2017
7Body Weight (Weight, Body)
01/2022 - 01/2014
7Fibrosis (Cirrhosis)
01/2021 - 01/2014
7Carcinogenesis
03/2020 - 01/2005
7Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 04/2008
6Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 06/2004
6Hypoxia (Hypoxemia)
03/2020 - 01/2014
5Stroke (Strokes)
09/2022 - 12/2017
5Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
08/2022 - 11/2018
5Glioma (Gliomas)
07/2022 - 10/2014
5Necrosis
03/2022 - 02/2015
5Stomach Neoplasms (Stomach Cancer)
02/2022 - 10/2014
5Adenocarcinoma of Lung
01/2022 - 02/2004
5Ischemic Stroke
01/2022 - 01/2018
5Postoperative Nausea and Vomiting (PONV)
10/2021 - 01/2015
5Colonic Neoplasms (Colon Cancer)
07/2021 - 09/2009
5Liver Diseases (Liver Disease)
01/2021 - 07/2016
5Pneumonia (Pneumonitis)
01/2021 - 07/2013
4Wounds and Injuries (Trauma)
09/2022 - 03/2016
4Thrombosis (Thrombus)
09/2022 - 01/2016
4Cerebral Infarction
06/2021 - 01/2017
4Sepsis (Septicemia)
04/2021 - 01/2015
4Osteoporosis
02/2021 - 01/2014
4Autoimmune Diseases (Autoimmune Disease)
10/2020 - 11/2015
4Melanoma (Melanoma, Malignant)
01/2020 - 12/2002
4Vomiting
06/2018 - 01/2015
4Atherosclerotic Plaque (Atheroma)
01/2018 - 02/2010
4Lung Neoplasms (Lung Cancer)
05/2017 - 02/2004
3Myocardial Infarction
04/2022 - 01/2017
3Ulcerative Colitis
03/2022 - 12/2019

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
03/2022 - 02/2003
25Pharmaceutical PreparationsIBA
11/2022 - 04/2006
18Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2016
16Biological ProductsIBA
07/2022 - 01/2005
13Messenger RNA (mRNA)IBA
01/2022 - 02/2010
11Sorafenib (BAY 43-9006)FDA Link
10/2022 - 10/2015
10MicroRNAs (MicroRNA)IBA
06/2022 - 11/2013
10Interleukin-6 (Interleukin 6)IBA
03/2022 - 05/2013
8Fluorouracil (Carac)FDA LinkGeneric
11/2022 - 04/2006
8Therapeutic UsesIBA
09/2022 - 04/2007
8DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2006
8EnzymesIBA
04/2021 - 07/2011
7Circular RNAIBA
07/2022 - 11/2017
7Peptides (Polypeptides)IBA
12/2021 - 09/2009
7Cisplatin (Platino)FDA LinkGeneric
10/2021 - 04/2006
7Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2021 - 11/2016
7BismuthIBA
08/2020 - 07/2013
7Apolipoproteins E (ApoE)IBA
01/2018 - 02/2010
6CytokinesIBA
03/2022 - 05/2013
6RNA (Ribonucleic Acid)IBA
01/2022 - 03/2015
6Doxorubicin (Adriamycin)FDA LinkGeneric
10/2021 - 10/2014
6CateninsIBA
02/2021 - 01/2014
6Small Interfering RNA (siRNA)IBA
01/2021 - 12/2013
6AntigensIBA
01/2021 - 06/2005
6GemcitabineFDA Link
07/2020 - 02/2004
5LipidsIBA
01/2022 - 01/2014
5Phosphotransferases (Kinase)IBA
12/2021 - 10/2015
5Indicators and Reagents (Reagents)IBA
09/2021 - 10/2014
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 11/2018
5Metronidazole (Metric)FDA LinkGeneric
08/2020 - 07/2013
5Levofloxacin (Levaquin)FDA Link
08/2020 - 10/2013
5Amoxicillin (Wymox)FDA LinkGeneric
08/2019 - 10/2013
5ApolipoproteinsIBA
01/2018 - 02/2010
5Cadherins (E-Cadherin)IBA
01/2016 - 08/2007
5VaccinesIBA
06/2015 - 06/2005
4Transcription Factors (Transcription Factor)IBA
02/2022 - 05/2017
4Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 04/2006
4Adenosine Triphosphate (ATP)IBA
10/2021 - 01/2017
4Chimeric Antigen ReceptorsIBA
05/2021 - 01/2019
4Folic Acid (Vitamin M)FDA LinkGeneric
01/2021 - 12/2013
4Clarithromycin (Biaxin)FDA LinkGeneric
08/2020 - 07/2013
4Hyaluronic Acid (Hyaluronan)IBA
01/2019 - 12/2015
4DexmedetomidineFDA Link
07/2015 - 01/2015
4DNA VaccinesIBA
04/2006 - 07/2003
3Etoposide (VP 16)FDA LinkGeneric
11/2022 - 12/2007
3Nonprescription Drugs (Patent Medicines)IBA
09/2022 - 06/2021
3NF-kappa B (NF-kB)IBA
03/2022 - 08/2007
3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
3Insulin (Novolin)FDA Link
01/2022 - 01/2015

Therapy/Procedure

74Therapeutics
07/2022 - 12/2003
19Hepatectomy
09/2022 - 01/2005
19Drug Therapy (Chemotherapy)
04/2022 - 01/2009
13Immunotherapy
01/2022 - 10/2006
10Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2021 - 01/2015
5Length of Stay
10/2021 - 12/2015
4Radiotherapy
12/2021 - 12/2016